Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 84
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Eksp Klin Farmakol ; 55(3): 52-4, 1992.
Artículo en Ruso | MEDLINE | ID: mdl-1458166

RESUMEN

It has been established in experiments on white rats that prolonged (for 2 weeks) intoxication with antituberculous drugs (isoniazid plus rifampicin plus pyrazinamide) results in cytolytic liver injury. This manifests by hyperaminotransferasemia, initiation of lipid peroxidation, suppression of the antioxidant system and bile production. Daily injections of tocopherol acetate (15 mg/kg) and riboxine (100 mg/kg) together with administration of antituberculous drugs reduce their hepatotoxicity. The combined use of these hepatoprotectors and antioxidants provides a dramatic increase of their efficacy in durable intoxication with antituberculous drugs.


Asunto(s)
Antituberculosos/toxicidad , Inosina Difosfato/uso terapéutico , Hígado/efectos de los fármacos , Vitamina E/análogos & derivados , alfa-Tocoferol/análogos & derivados , Animales , Antituberculosos/envenenamiento , Enfermedad Crónica , Evaluación Preclínica de Medicamentos , Quimioterapia Combinada , Masculino , Intoxicación/tratamiento farmacológico , Ratas , Tocoferoles , Vitamina E/uso terapéutico
3.
Eksp Klin Farmakol ; 55(2): 45-7, 1992.
Artículo en Ruso | MEDLINE | ID: mdl-1422454

RESUMEN

It has been established in experiments on white rats that antituberculous drugs (isoniazid, rifampicin, ethambutol) given in toxic doses affect the liver, its membranes and organelles, inhibit bile production and bioenergy. This is supported by activation of aspartate and alanine aminotransferases, (ALT and AST), alkaline phosphatase in blood serum and acid phosphatase in the liver, by a decrease of the activity of Na(+)-, K(+)-ATPase, succinate dehydrogenase and cytochromoxidase in the liver, lowering of the rate of bile secretion, excretion of bile acids, bilirubin and cholesterol with bile. Provided the drugs are administered in combination, the hepatotoxicity rises, particularly in combination of isoniazid with rifampicin, and especially as isoniazid is combined with rifampicin and ethambutol.


Asunto(s)
Etambutol/toxicidad , Isoniazida/toxicidad , Hígado/efectos de los fármacos , Rifampin/toxicidad , Animales , Bilis/efectos de los fármacos , Bilis/metabolismo , Interacciones Farmacológicas , Hígado/enzimología , Masculino , Ratas
4.
Eksp Klin Farmakol ; 55(1): 61-3, 1992.
Artículo en Ruso | MEDLINE | ID: mdl-1305440

RESUMEN

It has been shown in experiments on white rats that chronic (for one month) intoxication with CCl4 and C2H5OH results in liver injury. It manifests by activation of aminotransferases (ALT, AST) and alkaline phosphatase in blood serum, initiation of lipid peroxidation, depletion of the liver pool of reduced glutathione, and suppression of bile production. The liver preparations (sirepar and vitohepat) reduce hepatotoxicity of the poisons in question. The use of vitohepat and sirepar in combination with carsil potentiated hepatoprotective and antioxidative activity of the liver preparations.


Asunto(s)
Antioxidantes/uso terapéutico , Intoxicación por Tetracloruro de Carbono/tratamiento farmacológico , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Hepatitis Alcohólica/tratamiento farmacológico , Extractos Hepáticos/uso terapéutico , Silimarina/uso terapéutico , Animales , Intoxicación por Tetracloruro de Carbono/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Enfermedad Crónica , Evaluación Preclínica de Medicamentos , Quimioterapia Combinada , Hepatitis Alcohólica/sangre , Masculino , Ratas
6.
Probl Tuberk ; (3): 57-9, 1991.
Artículo en Ruso | MEDLINE | ID: mdl-1871097

RESUMEN

Two-week administration of isoniazid, rifampicin (50 mg/kg and pyrazinamide (1,5 g/kg) to white rats brings about liver affection characterized by a higher activity of alanine and aspartate aminotransferases, lipid peroxidation activation and bile production inhibition. With the liver affected by antituberculous drugs, protective action is provided by acetate tocopherol an antioxidant, and piracetam riboxin and pyriditol, antihypoxic agents.


Asunto(s)
Antioxidantes/uso terapéutico , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Modelos Animales de Enfermedad , Hepatitis Animal/tratamiento farmacológico , Inosina Difosfato/uso terapéutico , Isoniazida/efectos adversos , Piracetam/uso terapéutico , Pirazinamida/efectos adversos , Rifampin/efectos adversos , Vitamina E/uso terapéutico , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Hepatitis Animal/etiología , Isoniazida/antagonistas & inhibidores , Masculino , Pirazinamida/antagonistas & inhibidores , Ratas , Rifampin/antagonistas & inhibidores
8.
Probl Tuberk ; (10): 77-9, 1991.
Artículo en Ruso | MEDLINE | ID: mdl-1788241

RESUMEN

Isoniazid, rifampicin and ethambutol administered in equimolecular dosages (50, 250 and 100 mg/kg, respectively) for 4 days caused liver affection. This was manifested by elevated activity of serum aminotransferases and alkaline phosphatase, inhibition of lipid peroxidation of hepatocyte membranes and antioxidative system dysfunctions. Isoniazid and rifampicin were proved to be most hepatotoxic. The combined use of antituberculous drugs increases their membrane-damaging action, especially when isoniazid and rifampicin are used together, but mostly when isoniazid in combination with rifampicin and ethambutol is applied.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Modelos Animales de Enfermedad , Etambutol/toxicidad , Isoniazida/toxicidad , Hígado/efectos de los fármacos , Rifampin/toxicidad , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas/fisiopatología , Relación Dosis-Respuesta a Droga , Etambutol/administración & dosificación , Isoniazida/administración & dosificación , Hígado/fisiopatología , Pruebas de Función Hepática , Masculino , Ratas , Rifampin/administración & dosificación
9.
Farmakol Toksikol ; 53(6): 52-4, 1990.
Artículo en Ruso | MEDLINE | ID: mdl-2081569

RESUMEN

In experiments on albino rats it was established that three administrations of indomethacin in a dose of 0.01 g/kg body weight induced a severe damage of the liver characterized by disturbances of hepatocytic membranes, bile-producing and protein-producing functions of the liver, an enhancement of lipid peroxidation, a decrease of reduced glutathione pool. Antioxidants (tocopherol acetate, essentiale, legalon, flacumin) limit manifestations of indomethacin, hepatotoxicity, as a result of which tha functional-biochemical disorders in the liver show up to a lesser degree. During the combined use of antioxidants in indomethacin-induced lesions of the liver their hepatoprotective activity increases.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Indometacina/toxicidad , Animales , Antioxidantes/uso terapéutico , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Evaluación Preclínica de Medicamentos , Quimioterapia Combinada , Femenino , Peroxidación de Lípido/efectos de los fármacos , Ratas , Factores de Tiempo
17.
Farmakol Toksikol ; 50(3): 97-9, 1987.
Artículo en Ruso | MEDLINE | ID: mdl-3609289

RESUMEN

Carbon tetrachloride administered together with ethanol was found in experiments on male albino rats to cause a severe liver damage. The use of unithiol, flakumin, tocopherol acetate, silymarin and silybor and also their combinations under these conditions not only decreases lipid hyperperoxidation and prevents depletion of the reduced glutathione pool but also retains a functional liver disturbance. Silybor, silymarin and tocopherol acetate in combination with flakumin proved to be the most efficient.


Asunto(s)
Antioxidantes/uso terapéutico , Intoxicación por Tetracloruro de Carbono/tratamiento farmacológico , Enfermedad Hepática Inducida por Sustancias y Drogas , Hepatopatías Alcohólicas/tratamiento farmacológico , Animales , Intoxicación por Tetracloruro de Carbono/metabolismo , Evaluación Preclínica de Medicamentos , Hígado/efectos de los fármacos , Hígado/metabolismo , Hepatopatías/tratamiento farmacológico , Hepatopatías/metabolismo , Hepatopatías Alcohólicas/metabolismo , Masculino , Ratas
19.
Antibiot Med Biotekhnol ; 31(10): 781-4, 1986 Oct.
Artículo en Ruso | MEDLINE | ID: mdl-3789688

RESUMEN

It was shown in the experiments with albino rats that legalon and essentiale had a pronounced hepatoprotective effect in tetracycline affections of the liver. They retarded the increase in the activity of alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase in blood serum, prevented suppression of cholopoiesis by tetracycline and inhibited lipid peroxidation. The drugs may be used for prevention and treatment of tetracycline affections of the liver.


Asunto(s)
Antioxidantes/uso terapéutico , Flavonoides/uso terapéutico , Hepatopatías/tratamiento farmacológico , Fosfatidilcolinas/uso terapéutico , Plantas Medicinales , Silimarina/uso terapéutico , Tetraciclina/toxicidad , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas , Evaluación Preclínica de Medicamentos , Quimioterapia Combinada , Masculino , Ratas
20.
Farmakol Toksikol ; 49(4): 86-9, 1986.
Artículo en Ruso | MEDLINE | ID: mdl-3758339

RESUMEN

In male albino rats tocopherol acetate and sodium selenite were shown to be efficient in treatment of isoniazide-induced liver damage. The disturbances of secretion of bile, bile acids and bilirubin and excretion of cholesterol were less pronounced. A decrease of the activity of marker blood serum enzymes--alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase--also indicated the hepatoprotective effect of these drugs. The intensity of lipoperoxidation indicated by a decrease of lipid peroxidation indices in the liver and blood was diminished. Tocopherol acetate and sodium selenite increase the number of sulfhydryl groups but decrease the number of disulfide groups in these biosubstrates.


Asunto(s)
Antioxidantes/uso terapéutico , Isoniazida/toxicidad , Hepatopatías/tratamiento farmacológico , alfa-Tocoferol/análogos & derivados , Animales , Enfermedad Hepática Inducida por Sustancias y Drogas , Evaluación Preclínica de Medicamentos , Quimioterapia Combinada , Hígado/efectos de los fármacos , Hígado/metabolismo , Hepatopatías/metabolismo , Masculino , Ratas , Ácido Selenioso , Selenio/uso terapéutico , Tocoferoles , Vitamina E/análogos & derivados , Vitamina E/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA